Skip to main content

Advertisement

Log in

Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

An Erratum to this article was published on 01 August 2005

Summary

Galectins, β-galactoside binding proteins, expressed selectively in human breast carcinoma are attractive targets to employ lectin-aimed therapeutics. We examined β-galactoside binding potency of neoplastic cells using fluorescein-labelled synthetic glycoconjugates as probes for flow cytometry. As a result, surface β-galactoside binding proteins/galectins were discovered on mouse mammary carcinoma cells in vitro and in vivo unlike non-malignant cells from the several tissues; and asialo-GM1 ganglioside carbohydrate part - containing probe was the most specific one. However, in liver and lung metastatic cells galectins seem to be expressed within cytoplasm and/or nuclei. Galectin expression correlated directly with aggressive tumour potential in the A/Sn transplantable model similar to findings in several human breast carcinoma cell lines. However, galectin expression was reduced during tumour progression in more aggressive forms of spontaneous BLRB mammary carcinomas like it was shown for human breast carcinoma specimens. Analysis of the histopathological data led, however, to the conclusion that galectin expression hardly might be a suitable marker of aggressiveness of heterogeneous mammary carcinomas as the observed level of galectin expression is influenced by the amount of the stroma in a tumour sample and/or probably, galectin expression inversely correlates with tumour aggressiveness during the initial and advanced steps of mammary tumour progression. We conclude that surface β-galactoside binding proteins/galectins that are selectively expressed during mouse mammary carcinoma progression, similarly to human breast carcinomas, seem to be proper targets for asialo-GM1-vectored cytotoxics and our mouse model system might be a relevant instrument to further test novel modes of anti-breast cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

aGM1, Galβ1-3GalNAcβ1-4Galβ1-4Glcβ:

asialo-GM1 ganglioside carbohydrate part

βGBP:

β-galactoside binding protein

BC:

breast cancer

BSA:

bovine serum albumin

Glyc-PAA-fluo :

polyacrylamide glycoconjugate probes labeled with fluorescein

LacNAc:

Galβ1-4GlcNAcβ, lactosamine disaccharide

PAS:

Periodic Acid -Schiff staining

PBS:

phosphate buffered saline

PBA:

PBS containing 0.2% BSA

PI:

proliferation index

SiaLex :

Neu5Acα2-3 Galβ1-4(Fucα1-3)GlcNAc tetrasaccharide

Tαα :

Galβ1-3GalNAcα disaccharide

Versene solution:

PBS containing 0.02% EDTA

References

  1. M Morrow W Gradishar (2002) ArticleTitleBreast cancer Br Med J 324 410–414

    Google Scholar 

  2. HM Ogmundsdottir (2001) ArticleTitleImmune reaction to breast cancer: for better or for worse? Arch Immunol Ther Exp 49 IssueIDsuppl. 2 S75–S81

    Google Scholar 

  3. TA Pluncett I Correa DW Miles J Taylor-Papadimitriou (2001) ArticleTitleBreast cancer and the immune system: opportunities and pitfalls J Mammary Gland Biol Neoplasia 6 467–475 Occurrence Handle10.1023/A:1014743232598 Occurrence Handle12013535

    Article  PubMed  Google Scholar 

  4. JR Harris M Morrow G Bonadonna (1993) Cancer of the breast VT De Vita S Helman SA Rosenberg (Eds) Cancer. Principles and Practice of Oncology JB Lippincot Philadelphia 1264–1332

    Google Scholar 

  5. RO Dillman LD Beutel C De Leon ShK Nayak (2001) ArticleTitleShort-term tumour cell lines from breast cancer for use as autologous tumour cell vaccines in the treatment of breast cancer Cancer Biotherapy Radiopharm 16 205–211 Occurrence Handle10.1089/10849780152389393

    Article  Google Scholar 

  6. NV Bovin (1998) ArticleTitlePolyacrylamide-based neoglycoconjugates as tools in glycobiology Glycoconj J 15 431–446 Occurrence Handle10.1023/A:1006963717646 Occurrence Handle9881745

    Article  PubMed  Google Scholar 

  7. N Yamazaki S Kojima NV Bovin S Andre S Gabius HJ Gabius (2000) ArticleTitleEndogenous lectins as targets for drug delivery Adv Drug Deliv Rev 43 225–244 Occurrence Handle10.1016/S0169-409X(00)00071-5 Occurrence Handle10967228

    Article  PubMed  Google Scholar 

  8. EL Vodovozova EV Moiseeva GK Grechko GP Gayenko NE Nifant’ev NV Bovin JG Molotkovsky (2000) ArticleTitleAntitumor activity of cytotoxic liposomes equipped with selectin ligand SiaLex, in mouse mammary adenocarcinoma Eur J Cancer 36 942–949 Occurrence Handle10.1016/S0959-8049(00)00029-0 Occurrence Handle10785601

    Article  PubMed  Google Scholar 

  9. GA Rabinovich (1999) ArticleTitleGalectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy Cell Death Different 6 711–721 Occurrence Handle10.1038/sj.cdd.4400535

    Article  Google Scholar 

  10. A Varki R Cummings J Esko H Freeze G Hart J Marth (Eds) (1999) Essentials of Glycobiology, Consortium of Glycobiology Editors La Jolla California

    Google Scholar 

  11. A Dangue I Camby R Kiss (2002) ArticleTitleGalectins and cancer Biochim Biophys Acta 1572 285–293 Occurrence Handle12223276

    PubMed  Google Scholar 

  12. L Chiariotti P Salvatore R Frunzio CB Bruni (2004) ArticleTitleGalectin genes: regulation of expression Glycoconj J 19 441–449 Occurrence Handle10.1023/B:GLYC.0000014073.23096.3a Occurrence Handle14758067

    Article  PubMed  Google Scholar 

  13. SK Khaldoyanidi VV Glinsky L Sikora AB Glinskii VV Mossine TP Quinn GV Glinsky P Sriramarao (2003) ArticleTitleMDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions J Biol Chem 278 4127–4134 Occurrence Handle10.1074/jbc.M209590200 Occurrence Handle12438311

    Article  PubMed  Google Scholar 

  14. YK Song TR Billiar YJ Lee (2002) ArticleTitleRole of galectin-3 in breast cancer metastasis: involvement of nitric oxide Am J Pathol 160 1069–1075 Occurrence Handle11891203

    PubMed  Google Scholar 

  15. H Idikio (1998) ArticleTitleGalectin-3 expression in human breast carcinoma: correlation with cancer histological grade Int J Oncol 12 1287–1290 Occurrence Handle9592187

    PubMed  Google Scholar 

  16. F Vanden Brule S Califice V Castronovo (2004) ArticleTitleExpression of galectins in cancer: a critical review Glycoconj J 19 537–542 Occurrence Handle10.1023/B:GLYC.0000014083.48508.6a Occurrence Handle14758077

    Article  PubMed  Google Scholar 

  17. H-RCh Kim Hu-M Lin H Biliran A Raz (1999) ArticleTitleCell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells Cancer Res 59 4148–4154 Occurrence Handle10463621

    PubMed  Google Scholar 

  18. A Paz R Haklai G Elad-Sfadia E Ballan J Kloog (2001) ArticleTitleGalectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation Oncogene 20 7486–7493 Occurrence Handle10.1038/sj.onc.1204950 Occurrence Handle11709720

    Article  PubMed  Google Scholar 

  19. P Nangia-Makker Y Honjo R Sarvis S Akahani V Hogan KJ Pienta A Raz (2000) ArticleTitleGalectin-3 induces endothelial cell morphogenesis and angiogenesis Am J Pathol 156 899–909 Occurrence Handle10702407

    PubMed  Google Scholar 

  20. Mouse Genome Informatics http://www.informatics.jax.org/external/festing/mouse/docs/BLRB.shtml and http://www. informatics.jax.org/external/festing/mouse/docs/CBRB.shtml

  21. EV Moiseeva IB Merkulova C Bijleveld J-W Koten AI Miroshnikov W Den Otter (2003) ArticleTitleTherapeutic effect of single peritumoural dose of IL-2 on transplanted murine breast cancer Cancer Immunol Immunother 52 487–496 Occurrence Handle10.1007/s00262-003-0385-8 Occurrence Handle12719897

    Article  PubMed  Google Scholar 

  22. Moiseeva E, Chaadaeva A, Bojenko V, Mehdipour P, Den Otter W: Mouse naturally arising mammary cancer: promising link to familial set of breast cancer. In: Proceedings of the First International Congress on Cancer Genetics, Tehran University of Medical Sciences, December 13–16 2003, Publisher of Deputy Research, Tehran, 2003, p 102.

  23. E Rapoport S Khaidukov O Baidina V Bojenko E Moiseeva G Pazynina U Karsten N Nifant’ev J LePendu N Bovin (2003) ArticleTitleInvolvement of the Galbeta1 – 3GalNAcbeta structure in the recognition of apoptotic bodies by THP-1 cells Eur J Cell Biol 82 295–302 Occurrence Handle10.1078/0171-9335-00314 Occurrence Handle12868597

    Article  PubMed  Google Scholar 

  24. H Leffler (2001) Galectins structure and function – a synopsis in Mammalian Carbohydrate recognition systems R Crocker Paul (Eds) Mammalian Carbohydrate Recognition Systems Springer-Verlag Berlin–Heidelberg 57–83

    Google Scholar 

  25. EV Korobko LP Saschenko EB Prockhorchouk IV Korobko NV Gnuchev SL Kiselev (1999) ArticleTitleResistance to tumour necrosis factor induced apoptosis in vitro correlates with high metastatic capacity of cells Immunol Lett 67 71–76 Occurrence Handle10.1016/S0165-2478(98)00143-6 Occurrence Handle10232385

    Article  PubMed  Google Scholar 

  26. HC Siebert S Andre SY Lu M Frank H Kaltner JA van Kuik EY Korchagina N Bovin E Tajkhorshid R Kaptein JFG Vliegenthart CW von der Leith J Jimenez-Barbero J Kopitz HJ Gabius (2003) ArticleTitleUnique conformer selection of the human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins Biochemistry 42 14762–14773 Occurrence Handle10.1021/bi035477c Occurrence Handle14674750

    Article  PubMed  Google Scholar 

  27. I Schmidt CH Uittenbogaart JV Giorgi (1991) ArticleTitleA gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification Cytometry 12 279–285 Occurrence Handle10.1002/cyto.990120312 Occurrence Handle1709845

    Article  PubMed  Google Scholar 

  28. Squartini F, Pingitore R: Tumours of the mammary gland. In: Turusov VA (ed) Pathology of Tumours in Laboratory Animals, Lyon, 1994, Vol. 2, pp 84–92.

  29. Z Kinkor I Svitakova A Ryska R Kodet P Hrabal (2002) ArticleTitleMetaplastic spindle-cell (fibromatosis-like) carcinoma of the breast-report of 4 cases Cesk Patol 38 164–168 Occurrence Handle12629863

    PubMed  Google Scholar 

  30. M Kriege CT Brekelmans C Boetes PE Besnard HM Zonderland IM Obdeijn RA Manoliu T Kok H Peterse MM Tilanus-Linthorst SH Muller S Meijer JC Oosterwijk LV Beex RA Tollenaar HJ Koning Particlede EJ Rutgers JG Klijn (2004) ArticleTitleEfficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 427–437 Occurrence Handle10.1056/NEJMoa031759 Occurrence Handle15282350

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Moiseeva.

Additional information

An erratum to this artcile can be found at http://dx.doi.org/10.1007/s10549-005-1747-z

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moiseeva, E.V., Rapoport, E.M., Bovin, N.V. et al. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer. Breast Cancer Res Treat 91, 227–241 (2005). https://doi.org/10.1007/s10549-005-0289-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-0289-8

Keywords

Navigation